ZIM LABORATORIES
Back to Balance Sheet
|
ZIM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹52 Cr | ₹53 Cr | ₹49 Cr | ₹30 Cr | ₹20 Cr |
What is the latest Total Non-Current Liabilities ratio of ZIM LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹52 Cr |
| Mar2025 | ₹53 Cr |
| Mar2024 | ₹49 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹20 Cr |
How is Total Non-Current Liabilities of ZIM LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹52 Cr | -1.95 | |
| Mar2025 | ₹53 Cr | 9.80 | |
| Mar2024 | ₹49 Cr | 59.79 | |
| Mar2023 | ₹30 Cr | 52.16 | |
| Mar2022 | ₹20 Cr | - | |
Compare Total Non-Current Liabilities of peers of ZIM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZIM LABORATORIES | ₹588.6 Cr | -1.3% | -9.2% | 37.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
ZIM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZIM LABORATORIES | -1.3% |
-9.2% |
37.8% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses